AMBALAL SARABHAI ENTERPRISES
Back to Balance Sheet
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹102 Cr | ₹103 Cr | ₹105 Cr | ₹129 Cr | ₹133 Cr |
What is the latest Total Current Liabilities ratio of AMBALAL SARABHAI ENTERPRISES ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹102 Cr |
Mar2023 | ₹103 Cr |
Mar2022 | ₹105 Cr |
Mar2021 | ₹129 Cr |
Mar2020 | ₹133 Cr |
How is Total Current Liabilities of AMBALAL SARABHAI ENTERPRISES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹102 Cr | -0.54 | |
Mar2023 | ₹103 Cr | -2.46 | |
Mar2022 | ₹105 Cr | -17.95 | |
Mar2021 | ₹129 Cr | -3.69 | |
Mar2020 | ₹133 Cr | - |
Compare Total Current Liabilities of peers of AMBALAL SARABHAI ENTERPRISES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AMBALAL SARABHAI ENTERPRISES | ₹373.5 Cr | 10.8% | -13.1% | -16.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹417,472.0 Cr | 0.2% | -5.8% | 23.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,342.0 Cr | 4.8% | 0% | 53.8% | Stock Analytics | |
CIPLA | ₹114,754.0 Cr | -0.2% | -4.7% | 3.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,465.0 Cr | 1.9% | -10.9% | 0.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,875.2 Cr | 3.2% | 0.1% | 28.1% | Stock Analytics |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AMBALAL SARABHAI ENTERPRISES | 10.8% |
-13.1% |
-16.4% |
SENSEX | 1.7% |
-2.6% |
7.6% |
You may also like the below Video Courses